|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 70.49 CNY | -1.80% |
|
-2.84% | +3.56% |
| 01-22 | Gan & Lee Pharmaceuticals Expects 2025 Profit to Jump Up to 95% | MT |
| 01-15 | Gan & Lee Pharmaceuticals Gets EU Approval for Insulin Injection; Shares Up 4% | MT |
Chart calendar Gan & Lee Pharmaceuticals.
Upcoming events on Gan & Lee Pharmaceuticals.
| 22/04/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format |
| 23/04/2026 | Q1 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 20/08/2026 | Q2 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 21/10/2026 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 28/04/2027 | Q4 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
Past events on Gan & Lee Pharmaceuticals.
| 30/10/2025 | Q3 2025 Earnings Release |
| 07/08/2025 | Q2 2025 Earnings Release |
| 24/04/2025 | Q1 2025 Earnings Release |
| 24/04/2025 | Q4 2024 Earnings Release |
| 22/10/2024 | Q3 2024 Earnings Release |
| 28/08/2024 | Q2 2024 Earnings Release |
| 16/05/2024 | Annual General Meeting |
| 24/04/2024 | Q1 2024 Earnings Release |
| 24/04/2024 | Q4 2023 Earnings Release |
| 11/03/2024 | Extraordinary Shareholders Meeting |
| 30/10/2023 | Q3 2023 Earnings Release |
| 11/09/2023 | Extraordinary Shareholders Meeting |
| 24/08/2023 | Q2 2023 Earnings Release |
| 27/04/2023 | Q1 2023 Earnings Release |
| 19/04/2023 | Annual General Meeting |
| 30/03/2023 | Q4 2022 Earnings Release |
| 13/03/2023 | Extraordinary Shareholders Meeting |
| 15/11/2022 | Extraordinary Shareholders Meeting |
| 27/10/2022 | Q3 2022 Earnings Release |
| 25/08/2022 | Interim 2022 Earnings Release |
Past dividends on Gan & Lee Pharmaceuticals.
| 10/06/2025 | Final Payment 1 CNY |
| 01/12/2024 | Interim Payment 0.5 CNY |
| 17/06/2024 | Annual 0.2 CNY |
| 19/06/2022 | Annual 0.3 CNY |
| 20/05/2021 | Annual 0.4 CNY |
| 19/08/2020 | Annual 0.5 CNY |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 0,00 | 2 608 2 585 0.88% | 3 045 3 351 -9.11% | 4 178 | 5 191 | 6 057 |
|
EBITDA Million CNY | Released Forecast Spread | 0,00 | 538 584 -7.93% | 796 874 -8.91% | 1 387 | 1 853 | 2 268 |
|
EBIT Million CNY | Released Forecast Spread | 0,00 | 315 413 -23.66% | 632 767 -17.66% | 1 209 | 1 594 | 1 951 |
|
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 0,00 | 306 417 -26.58% | 630 765 -17.54% | 1 269 | 1 595 | 1 952 |
|
Net income Million CNY | Released Forecast Spread | -440 | 340 322 5.73% | 615 661 -7.05% | 1 090 | 1 450 | 1 792 |
|
EPS CNY | Released Forecast Spread | -0,78 | 0,60 0,53 13.21% | 1,04 1,10 -5.17% | 1,84 | 2,41 | 2,98 |
| Announcement Date | 30/03/23 | 24/04/24 | 24/04/25 | - |
Quarterly results
| Fiscal Period | September | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 560 654 -14.29% | 755 792 -4.78% | 930 1 029 -9.6% | 800 1 018 -21.4% | 985 746 31.99% | 1 082 1 112 -2.69% | 980 1 140 -13.99% | 1 103 | 985 | 1 720 | 1 387 |
|
EBITDA Million CNY | Released Forecast Spread | 367 | 355 | 357 | 541 | 458 | ||||||
|
EBIT Million CNY | Released Forecast Spread | 113 | 226 | 69,3 | 299 | 333 | 237 | |||||
|
EPS CNY | Released Forecast Spread | 0,16 0,23 -30.43% | 0,35 0,35 0% | 0,35 0,24 45.83% | 0,19 0,22 -13.64% | 0,53 0,33 60.61% | 0,49 0,52 -5.77% | 0,36 0,51 -29.41% | 0,45 | 0,40 | 0,66 | 0,54 |
| Announcement Date | 24/04/24 | 28/08/24 | 22/10/24 | 24/04/25 | 24/04/25 | 07/08/25 | 30/10/25 | - | - | - | - |
| 30/01/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 02/02/2026 | Q1 2026 Earnings Release | Add to your calendar Google Apple ICS format | |
| 02/02/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 04/02/2026 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 04/02/2026 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 05/02/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 05/02/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 10/02/2026 | Q2 2026 Earnings Release | Add to your calendar Google Apple ICS format | |
| 12/02/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 12/02/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format |
Past sector events for Gan & Lee Pharmaceuticals.
| 21/01/2026 | Q4 2025 Earnings Release | |
| 19/01/2026 | Q2 2026 Sales and Revenue Release - Trading Update | |
| 09/01/2026 | December 2025 Sales and Revenue Release | |
| 11/12/2025 | Q4 2025 Earnings Release | |
| 08/12/2025 | November 2025 Sales and Revenue Release | |
| 14/11/2025 | Q4 2025 Earnings Release | |
| 14/11/2025 | Q3 2025 Earnings Release | |
| 13/11/2025 | Q3 2025 Earnings Release | |
| 13/11/2025 | Q3 2025 Earnings Release | |
| 13/11/2025 | Q3 2025 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 603087 Stock
- Calendar Gan & Lee Pharmaceuticals.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















